interferon-α
Interferon Alpha for Children with Chronic Hepatitis B: Long-Term Treatment Effects
Results of a 13-Year Study
Interferon Alpha-2b Enhances Protection Against Omicron in Vaccinated Individuals
A Study on High-Risk Medical Workers
Modified Interferon α2 Inhibits Coronavirus Replication and Inflammation
IFNmod protects against IFN-I-associated lung injury
Interferon-α Inhibits Melanoma Metastasis
IFN-alpha reduces the ability of cancer stem cells to form tumors
Interferon α2b and Vitamin D Reduce Inflammation in Vaginal Infections in Pregnancy
Influence of complex therapy on the balance of cytokines
Lacidophilin Improves The Efficacy of Interferon α-2b in Treating Human Papillomavirus
Safe prevention of cervical cancer in HPV patients
Efficacy and Safety of Interferon-Alpha for the Treatment of RSV Pneumonia in Infants
Symptoms resolve much faster
Prevention of Interferon-Alpha-induced Depression
How antidepressants, sleep, and cytokine IL-6 influence the risk of depression
Zinc Supplements Enhance Interferon Synthesis in the Elderly
However, an overdose of zinc lowers immune function
Efficacy and Safety of Type I and III Interferons in the Treatment of COVID-19
Systematic review and meta-analysis
Prevention of COVID-19 in Pregnant Women
Evaluation of the effectiveness of intranasal and rectal interferon-alpha, vaccination and umifenovir
The Introduction of Intranasal Interferon-Alpha During COVID-19 Vaccination Increases the Effectiveness and Longevity of Vaccines
IFN-alpha forms sterilizing immunity of the mucous membranes of the upper respiratory tract
Interferon-Alpha-2b and Reduning to Treat Viral Pneumonia in Children
Interferon increases the effectiveness of treatment and reduces the symptoms of pneumonia
Interferon-α2b Spray Shortens The Infectious Period of Omicron
Only administration up to 3 days from the onset of the disease is effective
Omicron and Delta are The Most Interferon-Resistant COVID-19 Strains
IFN-alpha8, IFN-beta, and IFN-omega coronavirus are most effectively suppressed
Nasal Interferon is Only Effective if Administered before COVID-19 Symptoms Appear
Interferon-alpha is effective the day before or one day after infection with SARS-CoV-2
Interferon-Alpha to Treat Uterine Fibroids
Interferon irreversibly reduces the size of fibroids, preserving fertility
Interferon-Alpha-2b Improves The Effect of Antifungal Drugs in Thrush Treatment
Interferon enhances the immune response in vulvovaginal candidiasis
Interferon-Alpha-2b Is Effective and Safe to Treat Ocular Surface Squamous Neoplasia
The tumor resolved entirely in 83% of cases.
Treating Seasonal Allergies: Azelastine or Interferon with Betamethasone?
Combined preparation of interferon-alpha-2b quickly reduces the symptoms of hay fever
Interferon And Lactation: Clinical Experience with Interferon-Alpha in Breastfeeding
Does interferon-alpha pass into breast milk?
Interferon-Alpha-11 to Treat Immunodeficiency Virus
Interferon-alpha-11, but not interferon-beta, suppresses chronic retroviral infection
GMOP-IFN-Alpha-2b: Stable De-Immunized Interferon
Non-immunogenic interferon with a long elimination period can help in the treatment of chronic hepatitis and other viral diseases
Interferon-Alpha-2b to Treat Ocular Surface Tumors
Can we use interferon without a refrigerator?
Interferons to Treat and Prevent Diabetic Retinopathy
Interferon-alpha inhibits vascular proliferation in advanced diabetic retinopathy
Physical Activity after COVID-19 and Flu Vaccination Increases The Level of Antibodies
Physical activity stimulates the production of interferon-alpha and increases the effectiveness of vaccines
Interferon-Alpha-2b Inhalations Improve Clinical Outcome in COVID-19
Early treatment with interferon-alpha-2b reduces the risk of severe COVID-19 outcomes by 64%
Interferon-Alpha in COVID-19: A Systematic Review
Interferon-alpha in combination with antivirals accelerates recovery from COVID-19
Genetically Engineered IFN vs Conventional IFN Against COVID-19
New genetically engineered interferon-alpha accelerates clinical improvement in coronavirus
Combined Nafamostat and Interferon-Alpha Suppresses The SARS-Cov-2
The drugs have a synergistic effect in vitro and in vivo due to the joint impact on TMPRSS2
Interferon Autoantibodies Increase The Risk of Critical COVID-19 in Elders
Autoantibodies that neutralize type I interferons are present in 4% of uninfected people over 70 and are responsible for 20% of deaths from COVID-19
Intranasal Form of Interferon-Alfa-2b for The Prevention and Treatment Of COVID-19
Small doses of interferon are required to obtain a beneficial effect
Dynamics of Interferon-Alpha in The Blood of Patients with COVID-19
Prospective observational study
COVID-19-free Holidays: How to Travel Safely
Interferon will enhance COVID-19 prevention measures on airplanes
Interferon-alpha-2b Accelerates The Recovery Of Children With Herpangina
A randomized, double-blind, controlled trial
Interferon-α2b inhalation improves clinical outcomes in COVID-19 patients
The timing of treatment initiation is crucial – up to 5 days from the onset of symptoms
Interferon alpha-2b accelerates recovery in rotavirus
Rectal suppositories of interferon-a2b reduce the clinical manifestations of rotavirus gastroenteritis in newborns
Physical rest and interferon to treat chronic cough in horses
Clinical trial on young standardbreds
Interferon-α prevents and treats avian influenza H9N2 in chickens
Clinical study on 7-day-old and 33-day-old chickens
Interferon alpha-2b approved for COVID-19 treatment in India
The Indian regulator allowed the use of pegylated interferon-a2b in emergency cases
Treatment of follicular lymphoma with tumor injections of dendritic cells treated with interferon-α2b
Clinical trial, Phase 1
Interferon-alpha Reduces Recurrent Bacterial Vaginosis Frequency in Pregnant
Randomized study of vaginal biocenosis during gestation
Interferon Deprives Chlamydia for Reproduction
Research on human epithelial cell culture
Interferons in the pathogenesis of bacterial infections
Interferons can increase or decrease the disease depending on the type of bacterium, the disease stage, the path of infection, or the body's characteristics
Interferon- α2b in postherpetic neuralgia
High-frequency current combined with interferon-α2b injection successfully treats shingles neuralgia
Interferon-alpha to protect people with immune suppression from COVID-19
No patients infected with COVID-19 within 45 days of the study
Interferon-α2b in Treatment of Coronavirus Diseases, Influenza and SARS
Clinical trials for prevention and treatment. World experience in the use of IFN-α from COVID-19, influenza, acute respiratory infections: recommendations of national health authorities
Interferons alpha-2a and alpha-2b for eye diseases
Interferons' treatment of the anterior and posterior segments of the eyeball
Microbiota protects against the flu
Tonic interferon signals in the stroma of the lungs are controlled by the microbiota and increase resistance to flu
The COVID-19 pandemic has increased the intensity of interferon studies
The research of interferon-alpha-2b for the treatment and prevention of COVID-19 has the most significant interest
Early interferon therapy reduces mortality in patients with COVID-19
A retrospective cohort multi-study
Severe COVID-19 is associated with SARS-CoV-2 ability to suppress interferon production
Interferon beta is not detecting in the body of infected people. The level of interferon-alpha decreases with increasing severity of the disease
COVID-19 prevention drug is free to give in Khanty-Mansi region
A drug containing recombinant interferon alfa-2b will be distributed to families with COVID-19 patients. This interferon is recommended by the Russian Ministry of Health for drug prevention of COVID-19
Type I interferons as a perspective treatment for COVID-19
Efficacy and safety of IFN-I in treating the new coronavirus
Vitamins and trace elements against anxiety and depression
Optimal nutrient level protects against mental disorders
Treating herpes locally: comparing combined and monotherapy
A combination of drugs affects different mechanisms of viruses’ reproduction. Monotherapy is strong with a higher concentration of the active substance
SARS prevention raises allergy treatment effect
Interferon-alpha-2b and loratadine-based nasal medications contribute to the treatment regimen preservation of allergic diseases during the SARS epidemic
Treating the feline herpesvirus-1: Comparison of feline and human interferon efficacy
Recombinant feline interferon-omega suppresses herpesvirus in vitro replication much more actively than human recombinant interferon-alpha-2b. Maximum antiviral activity is observed in homologous cells
Prevention and treatment of COVID-19. Russian Ministry of Health review. Version 8, 03.09.2020.
Ministry of Health experts have summarized a cumulative Russian and worldwide experience of treating and preventing SARS-CoV-2. Useful information is collected in temporary guidelines
Covid-19 experimental treatment with nebulized interferon-α2b accelerates recovery by 30%
IFN-α2b aerosol normalizes the indicators of the interleukin-6 and C-reactive protein acute phase of inflammation. It prevents the development of an autoimmune reaction and body tissues damage
China’s successful experience in preventing COVID-19 in non-infected medical stuff
None of the doctors at the Taihe hospital in Shiyan, Hubei province, got the virus within 28 days. 3-level protection: nasal interferon-α2b (4 times a day), thymosin-α1 once a week (subcutaneous)
The role of interferon in the pathogenesis of human infectious diseases (by Andrey S. Simbirtsev – MD, PhD, Prof)
The function of interferon is to force the body's antiviral activity
New treatment for hepatitis C: faster effect, better survival rate
While scientists argue what is more harmful: the disease itself or the side effects of drugs, the hepatitis C community in the United States shares good news. Modern hepatitis C therapy in 97% of cases passes without serious health consequences within 2 years